AXIM BIOTECHNOLOGIES, INC. (AXIM) › RevenueAXIM BIOTECHNOLOGIES, INC. (AXIM) — RevenueAnnual figures by fiscal year, from SEC filings.2011: $10.0K2012: $43.3K2014: $02015: $49.1K2016: $47.1K2017: $47.6K2018: $195.6K2019: $799.5K2020: $02021: $60.5K2022: $8.9K2023: $39.5K$39.5K2011Revenue (USD)2023Fiscal YearRevenueChange YoY2023$39.5K+345.3%2022$8.9K-85.3%2021$60.5K—2020$0-100.0%2019$799.5K+308.7%2018$195.6K+311.2%2017$47.6K+1.1%2016$47.1K-4.2%2015$49.1K—2014$0—2012$43.3K+333.3%2011$10.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share